Daniel W. Muehl, See Remarks at Clovis Oncology, Inc. (CLVS), sold 4,523 shares at $4.55 ($21K) on 2021-11-02, disclosed to the SEC on 2021-11-03.
Seasonal sale ($21k) by See Remarks — this insider has traded CLVS in November in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.55 | 2,041 | $9K | 45.1% |
| 2 | $4.55 | 2,482 | $11K | 54.9% |
| Total | $4.55 avg | 4,523 | $21K | 100% |
| Filing → |
| CLVS | SELL | 2022-08-03 | $7K | — | Filing → |
| CLVS | SELL | 2022-06-03 | $1K | — | Filing → |
| CLVS | SELL | 2022-05-03 | $9K | — | Filing → |